نویسندگان | Jafar Mohseni- ZAMH Zabidi-Hussin- Teguh Haryo Sasongko |
---|---|
نشریه | Genetics and Molecular Biology |
ارائه به نام دانشگاه | USM |
شماره صفحات | 299-307 |
شماره سریال | 3 |
شماره مجلد | 36 |
ضریب تاثیر (IF) | 0.5 |
نوع مقاله | Full Paper |
تاریخ انتشار | 2013 |
رتبه نشریه | ISI (WOS) |
نوع نشریه | چاپی |
کشور محل چاپ | ایران |
چکیده مقاله
Histone acetylation plays an important role in regulation of transcription in eukaryotic cells by promoting a more relaxed chromatin structure necessary for transcriptional activation. Histone deacetylases (HDACs) remove acetyl groups and suppress gene expression. HDAC inhibitors (HDACIs) are a group of small molecules that promote gene transcription by chromatin remodeling and have been extensively studied as potential drugs for treating of spinal muscular atrophy. Various drugs in this class have been studied with regard to their efficacy in increasing the expression of survival of motor neuron (SMN) protein. In this review, we discuss the current literature on this topic and summarize the findings of the main studies in this field.
tags: HDACi; molecular therapy; spinal muscular atrophy